Stories

A supervisor in the lab that's at the heart of Mayo Clinic Laboratories' COVID-19 testing, Dave Majewski's job has changed dramatically in the last year, as he went from overseeing about 40 staff members to more than 240 in a lab that now runs 24/7.

This week’s research roundup features a study on trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic Laboratories.

This week’s research roundup features an expert review of the AGA clinical practice update on the management of refractory helicobacter pylori infection.

A genetic counselor with Mayo Clinic Laboratories for the last 15 years, Cassie Runke relishes her role serving as a resource for health care providers who are looking to help their patients find answers through genetic testing.

Top highlights include: understanding the effectiveness and safety of the COVID-19 vaccine, COVID-19 terminology, and a patient's experience with a new Mayo Clinic platform.

This week’s research roundup features a study on in Patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity that represent two different phenotypes.

This week’s research roundup features a study on circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.

Top highlights include: maintaining your mental health during challenging times, concerns with COVID-19 variants, and unchecked COVID-19 spread leads to virus variants.

This week’s research roundup features a study on CD10 (Neprilysin) Expression: A potential adjunct in the sistinction of hibernoma from morphologic mimics.

With the rise of next generation sequencing (NGS) technology, multigene panel testing is expanding so rapidly that clinical practice is racing to keep pace. And questions within genetic tests have expanded along with it, making definitive answers more challenging to come by. Experts in the Genomics Laboratory in Mayo Clinic's Department of Laboratory Medicine and Pathology work to explain this often misunderstood technology.

Dendritic cells play a crucial role in the body's immune response. Research has shown that too few of these cells in the blood may signal a defect in innate immunity. Up to this point, however, no clinical test has been available to count dendritic cells.

This week’s research roundup features a study on changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).